Resistant Starch decreases the risk of cancer in patients with lynch syndrome in a randomized trial.

Zachariah H. Foda - CGA-IGC Communications Committee

Does starch prevent cancer in patients with lynch syndrome by a mechanism that might be applicable to the general population?

“Should we recommend taking resistant starch … it’s taken thirty years how long do you want to keep on going? Why would you not want to use this?”- Professor Sir John Burn, Newcastle University

In this episode, hosted by Swati G. Patel, MD, Gastroenterologist from the University of Colorado Anschutz Medical Center, Professor Sir John Burn, Professor of Clinical Genetics at Newcastle University, discusses the 10-year follow-up results of the seminal Cancer Prevention Programme (CAPP2) trial described in the Cancer Prevention Research